Weili Medical (603309.SH) announced semi-annual results, with net profit of 102 million yuan to mother, a year-on-year decrease of 15.76%

According to Zhitong Finance App News, Weili Healthcare (603309.SH) disclosed its 2026 semi-annual report. During the reporting period, the company achieved revenue of 769 million yuan, an increase of 3.18% over the previous year; net profit attributable to shareholders of listed companies was 102 million yuan, a year-on-year decrease of 15.76%; after deducting non-net profit of 98 million yuan, a year-on-year decrease of 16.68%; and basic earnings per share were 0.35 yuan.

During the reporting period, due to the launch of the sixth batch of national medical consumables, the price of domestic urology products dropped significantly, which had a certain impact on overall gross margin; in addition, due to fluctuations in foreign exchange, exchange losses increased, and financial expense ratios increased. Under the combined effects of the above multiple phased factors, the company's profit growth is under phased pressure.